Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization

Cardiovascular Revascularization Medicine

Volumn 9, Issue 4, 2008, Pages 229-234

  Lachance, Philippe ^a   Déry, Jean Pierre ^a   Rodés Cabau, Josep ^a   Potvin, Jean Michel ^a   Barbeau, Gérald ^a   Bertrand, Olivier F ^a   Gleeton, Onil ^a   Larose, Eric ^a   Nguyen, Can M ^a   Noël, Bernard ^a   Proulx, Guy ^a   Roy, Louis ^a   De Larochellière, Robert ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

CAD; FFR measurement; SPECT; Stress echocardiography

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; FRACTIONAL FLOW RESERVE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; ECHOCARDIOGRAPHY, STRESS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 53349101054     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2008.02.002     Document Type: Article

References (38)

1. Topol E.J., Ellis S.G., Cosgrove D.M., et al. Analysis of coronary angioplasty practice in the United States with insurance-claims data base. Circulation 87 (1993) 1489-1497
2. Kern M.J., Donohue T.J., Aguirre F.V., et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 25 (1995) 178-187
3. Pijls N., De Bruyne B., et al. Measurement of fractional flow reserve to asses the functional severity of coronary-artery stenoses. NEJM 334 (1996) 1703-1708
4. Kirkeeide R.L., Gould K.L., and Parsel L. Assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation: VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions. J Am Coll Cardiol 87 (1986) 1354-1367
5. Gould K.L., Kirkieeide R.L., and Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15 (1990) 459-474
6. Pijls N., Van son J.A.M., Kirkeeide R.L., De Bruyne B., and Gould K.L. Experimental basis of determining maximum coronary, myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87 (1993) 1354-1367
7. De Bruyne B., Baudhuin T., Melin J.A., et al. Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation 89 (1994) 1013-1022
8. De Bruyne B., Paulus W.J., and Pijls N.H. Rationale and application of coronary transstenotic pressure gradient measurements. Cathet Cardiovasc Diagn 33 (1994) 250-261
9. Pijls N.H.J., Bech G.J.W., el Gamal M.I.H., et al. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol 25 (1995) 1522-1528
10. Pijls N.H.J., Van Gelder B., Van der Voort P., et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92 (1995) 3183-3193
11. Scanlon P.J., Faxon D.P., Audet A.M., et al. ACC AHA guidelines for coronary angiography-a report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol 33 (1999) 1756-1816
12. Berman D.S., Germano G., and Shaw L.J. The role of nuclear cardiology in clinical decision making. Semin Nucl Med 29 (1999) 280-297
13. Fleischmann K.E., Hunink M.G., Kuntz K.M., and Douglas P.S. Exercise echocardiography or exercise SPECT imaging? A meta analysis of diagnostic test performances. JAMA 280 (1998) 913-920
14. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., and Camici P.G. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Eng J Med 330 (1994) 1782-1788
15. Zaret B.L., and Wackers F.J. Nuclear cardiology. N Eng J Med 329 (1993) 775-778
16. Henzlova M., Cerqueira M., Mahmarian J., and Yao S.S. Stress protocols and tracers. J Nucl Cardiol 13 6 (2006) 80-90
17. Chuah S.C., Pellikka P.A., Roger V.L., et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 97 (1998) 1474-1480
18. Quinones M.A., Waggoner A.D., Reduto L.A., et al. A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 61 (1981) 744-753
19. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
20. Pijls N.H., Van Gelber B., Van der Voort P., et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92 (1995) 3183-3193
21. Potvin J.M., and Rodés Cabeau J. Deferral of revascularization based on fractional flow reserve measurement in patients with acute coronary syndrome and/or non-invasive evidence of myocardial ischemia. Am J Cardiol 98 3 (2006 Aug 1) 289-297
22. Giesler T., Lamprecht S., and Voigt J.U. Long term follow up after deferral of revascularisation in patients with intermediate coronary stenoses and negative dobutamine stress echocardiography. Heart 88 (2002) 645-646
23. Davilla-Roman V.G., et al. Usefulness of dobutamine stress echocardiography for the prospective identification of the physiologic significance of coronary narrowings of moderate severity in patients undergoing evaluation for percutaneous transluminal coronary angioplasty. Am J Cardiol 76 (1995) 245-249
24. Leesar M.A., Abdul-Baki T., Akkus N.I., Sharma A., Kannan T., and Bolli R. Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcomes. J Am Coll Cardiol 41 (2003) 1115
25. Bech G.J., De Bruyne B., Bonnier H.J., et al. Long term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 31 (1998) 841
26. Ozdemir M., Timurkaynak T., Cemri M., et al. Medium-term follow-up of intermediate coronary stenoses left unrevascularized based on myocardial fractional flow reserve findings. Acta Cardiol 57 (2002) 335-340
27. Hernandez Garcia M.J., Alonso-Briales J.H., Jimenez-Navarro M., Gomez-Doblas J.J., et al. Clinical management of patients with coronary syndromes and negative fractional flow reserve findings. J Interv Cardiol 14 (2001) 505-509
28. Lopez-Palop R., Pinar E., Lozano I., Saura D., Pico F., and Valdes M. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J 25 (2004) 2040-2047
29. Chamuleau S.A., Meuwissen M., Koch K.T., et al. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol 89 (2000) 377-380
30. Rieber J., Jung P., Schiele T.M., et al. Safety of FFR-based treatment strategies: the Munich experience. Z Kardiol 91 suppl 3 (2002) 115-119
31. Lampe F.C., Whincup P.H., Wannamethee S.G., et al. The natural history of prevalent ischemic heart disease in middle-aged men. Eur Heart J 21 (2000) 1052-1062
32. The EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352 (1998) 87-92
33. De Bruyne B., Hersbach F., Pijls N., et al. Abnormal epicardial resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation 104 (2001) 2401-2406
34. Mintz G.S., Painter J.A., Pichard A.D., et al. Atherosclerosis in angiographically "normal" coronary artery reference: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 25 (1995) 1479-1485
35. Fleischmann K.E., and Hunking M.G. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic tests performance. JAMA 280 (1998) 913-920
36. Lopez-Palop R., Saura D., Pinar E., et al. Adequate intracoronary doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional flow reserve: a dose response study. Heart 90 (2004) 95-96
37. Murtagh B., Higano S., Lennon R., et al. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 146 (2003) 99-105
38. Parham W., Bouhasin A., Ciaramita J.P., Khouzaj S., et al. Coronary hyperaemic dose responses of intracoronary sodium nitroprusside. Circulation 109 (2004) 1236-1243